Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.8174
-0.0203 (-2.42%)
At close: Apr 7, 2026, 4:00 PM EDT
0.8600
+0.0426 (5.21%)
After-hours: Apr 7, 2026, 7:50 PM EDT

Cognition Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3725.0129.9241.5654.72
Cash & Short-Term Investments
3725.0129.9241.5654.72
Cash Growth
47.95%-16.42%-28.01%-24.05%954.56%
Other Receivables
9.922.691.283.672.27
Total Trade Receivables
9.922.691.283.672.27
Other Current Assets
1.071.863.022.412.01
Total Current Assets
47.9929.5634.2247.6558.99
Net Property, Plant & Equipment
0.40.680.941.050.15
Other Long-Term Assets
---1.73-
Total Assets
48.3930.2335.1650.4359.14
Accounts Payable
1.121.983.73.224.17
Accrued Expenses
127.624.062.091.75
Current Portion of Leases
0.140.190.170.15-
Unearned Revenue
0.371.071.71.70.75
Other Current Liabilities
0.310.280.540.631.19
Total Current Liabilities
13.9211.1410.177.87.86
Long-Term Leases
0.20.340.520.7-
Other Long-Term Liabilities
---1.69-
Total Long-Term Liabilities
0.20.340.522.38-
Total Liabilities
14.1211.4810.6910.187.86
Common Stock
0.090.060.030.030.02
Additional Paid-in Capital
232.83193.85165.83155.82145.45
Accumulated Other Comprehensive Income
---0.2-0.2-0.2
Retained Earnings
-198.65-175.16-141.19-115.4-94
Total Common Shareholders' Equity
34.2718.7524.4740.2551.27
Shareholders' Equity
34.2718.7524.4740.2551.27
Total Liabilities & Equity
48.3930.2335.1650.4359.14
Total Debt
0.330.540.690.840
Net Cash (Debt)
36.6724.4729.2340.7254.72
Net Cash Growth
49.83%-16.27%-28.22%-25.59%-
Net Cash Per Share
0.500.620.971.7210.54
Book Value
34.2718.7524.4740.2551.27
Book Value Per Share
0.470.470.821.709.88
Tangible Book Value
34.2718.7524.4740.2551.27
Tangible Book Value Per Share
0.470.470.821.709.88
Updated Mar 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q